Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acurx, Affimed, Alnylam, Asklepios, Astrazeneca, Bayer, BMS, Bugworks, Crinetics, Curis, Diamedica, Diamond, Galmed, GSK, Ionctura, Kalvista, Neoimmune, Nkgen, Novartis, Oncoinvent, Pieris, Regeneron, Selecta, Servier, Teva, TFF, Urovant.